Explanation
Co-amoxicav
Cholestatic/mixedcholestatic andhepatitisliver injurycamdevelopduringco-amoxiclav therapy or shortly
afterwards.Epidemiologicatstudies puttheriskof acutelivertoxict
é€ƒabout
times higher withco-
amoxiclav comparedtoamoxicillintherapyalone.Cholestaticuiver injury occursmorecommonyinpatients
aqed over65years andtis morecommoninmem;thesereactions arerarer inchildren.Thejaundice isusualy
self-limitinqandisrarelyfataL.
Thedurationofco-amoxiclavtherapv shouldbeappropriatetothe indicationand notexceed14davsonthe
adviceoftheCommitteeonSafetv ofMedicines.Rarer side-effects of co-amoxicav includeerythema
multiforme.toxiceoidermaLnecrolvsisandexfoliativedermatitis.
@1MIN ENDOCRINE
